Dissecting the microscopic steps of the cyclophilin A enzymatic cycle on the biological HIV-1 capsid substrate by NMR

Journal of Molecular Biology

Volumn 403, Issue 5, 2010, Pages 723-738

  Bosco, Daryl A ^a   Eisenmesser, Elan Zohar ^a   Clarkson, Michael W ^a   Wolf Watz, Magnus ^a   Labeikovsky, Wladimir ^a   Millet, Oscar ^b   Kern, Dorothee ^a  

^a BRANDEIS UNIVERSITY   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Backbone dynamics; Cyclophilin A; HIV 1 replication; NMR; Prolyl isomerase

Indexed keywords

CYCLOPHILIN A; PEPTIDYLPROLYL ISOMERASE;

ARTICLE; BINDING AFFINITY; CATALYSIS; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME METABOLISM; ENZYME SUBSTRATE; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR DYNAMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRUS CAPSID; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

EID: 77958515342     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2010.08.001     Document Type: Article

References (66)

1. Andreotti A.H. Native state proline isomerization: an intrinsic molecular switch. Biochemistry 2003, 42:9515-9524.
2. Wulf G., Finn G., Suizu F., Lu K.P. Phosphorylation-specific prolyl isomerization: is there an underlying theme?. Nat. Cell Biol. 2005, 7:435-441.
3. Lu K.P., Zhou X.Z. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat. Rev., Mol. Cell Biol. 2007, 8:904-916.
4. Brazin K.N., Mallis R.J., Fulton D.B., Andreotti A.H. Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A. Proc. Natl Acad. Sci. USA 2002, 99:1899-1904.
5. Sarkar P., Reichman C., Saleh T., Birge R.B., Kalodimos C.G. Proline cis-trans isomerization controls autoinhibition of a signaling protein. Mol. Cell 2007, 25:413-426.
6. Zhou X.Z., Kops O., Werner A., Lu P.J., Shen M., Stoller G., et al. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol. Cell 2000, 6:873-883.
7. Lu P.J., Wulf G., Zhou X.Z., Davies P., Lu K.P. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 1999, 399:784-788.
8. Pastorino L., Sun A., Lu P.J., Zhou X.Z., Balastik M., Finn G., et al. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature 2006, 440:528-534.
9. Lu K.P. Pinning down cell signaling, cancer and Alzheimer's disease. Trends Biochem. Sci. 2004, 29:200-209.
10. Nelson C.J., Santos-Rosa H., Kouzarides T. Proline isomerization of histone H3 regulates lysine methylation and gene expression. Cell 2006, 126:905-916.
11. Andreotti A.H. Opening the pore hinges on proline. Nat. Chem. Biol. 2006, 2:13-14.
12. Lummis S.C., Beene D.L., Lee L.W., Lester H.A., Broadhurst R.W., Dougherty D.A. Cis-trans isomerization at a proline opens the pore of a neurotransmitter-gated ion channel. Nature 2005, 438:248-252.
13. Bosco D.A., Eisenmesser E.Z., Pochapsky S., Sundquist W.I., Kern D. Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A. Proc. Natl Acad. Sci. USA 2002, 99:5247-5252.
14. Towers G.J. The control of viral infection by tripartite motif proteins and cyclophilin A. Retrovirology 2007, 4:40.
15. Min L., Fulton D.B., Andreotti A.H. A case study of proline isomerization in cell signaling. Front. Biosci. 2005, 10:385-397.
16. Schlegel J., Redzic J.S., Porter C.C., Yurchenko V., Bukrinsky M., Labeikovsky W., et al. Solution characterization of the extracellular region of CD147 and its interaction with its enzyme ligand cyclophilin A. J. Mol. Biol. 2009, 391:518-535.
17. Handschumacher R.E., Harding M.W., Rice J., Drugge R.J., Speicher D.W. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 1984, 226:544-547.
18. Schreiber S.L., Crabtree G.R. The mechanism of action of cyclosporin A and FK506. Immunol. Today 1992, 13:136-142.
19. Gamble T.R., Vajdos F.F., Yoo S., Worthylake D.K., Houseweart M., Sundquist W.I., Hill C.P. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 1996, 87:1285-1294.
20. Luban J. Absconding with the chaperone: essential cyclophilin-Gag interaction in HIV-1 virions. Cell 1996, 87:1157-1159.
21. Barik S. Immunophilins: for the love of proteins. Cell. Mol. Life Sci. 2006, 63:2889-2900.
22. Fischer G., Aumuller T. Regulation of peptide bond cis/trans isomerization by enzyme catalysis and its implication in physiological processes. Rev. Physiol. Biochem. Pharmacol. 2003, 148:105-150.
23. Yaffe M.B., Schutkowski M., Shen M., Zhou X.Z., Stukenberg P.T., Rahfeld J.U., et al. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 1997, 278:1957-1960.
24. Zydowsky L.D., Etzkorn F.A., Chang H.Y., Ferguson S.B., Stolz L.A., Ho S.I., Walsh C.T. Active site mutants of human cyclophilin A separate peptidyl-prolyl isomerase activity from cyclosporin A binding and calcineurin inhibition. Protein Sci. 1992, 1:1092-1099.
25. Eisenmesser E.Z., Millet O., Labeikovsky W., Korzhnev D.M., Wolf-Watz M., Bosco D.A., et al. Intrinsic dynamics of an enzyme underlies catalysis. Nature 2005, 438:117-121.
26. Jordens J., Janssens V., Longin S., Stevens I., Martens E., Bultynck G., et al. The protein phosphatase 2A phosphatase activator is a novel peptidyl-prolyl cis/trans-isomerase. J. Biol. Chem. 2006, 281:6349-6357.
27. Gothel S.F., Marahiel M.A. Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts. Cell. Mol. Life Sci. 1999, 55:423-436.
28. Lu K.P., Finn G., Lee T.H., Nicholson L.K. Prolyl cis-trans isomerization as a molecular timer. Nat. Chem. Biol. 2007, 3:619-629.
29. Mulder F.A., Mittermaier A., Hon B., Dahlquist F.W., Kay L.E. Studying excited states of proteins by NMR spectroscopy. Nat. Struct. Biol. 2001, 8:932-935.
30. Boehr D.D., Dyson H.J., Wright P.E. An NMR perspective on enzyme dynamics. Chem. Rev. 2006, 106:3055-3079.
31. Eisenmesser E.Z., Bosco D.A., Akke M., Kern D. Enzyme dynamics during catalysis. Science 2002, 295:1520-1523.
32. Labeikovsky W., Eisenmesser E.Z., Bosco D.A., Kern D. Structure and dynamics of Pin1 during catalysis by NMR. J. Mol. Biol. 2007, 367:1370-1381.
33. Wolf-Watz M., Thai V., Henzler-Wildman K., Hadjipavlou G., Eisenmesser E.Z., Kern D. Linkage between dynamics and catalysis in a thermophilic-mesophilic enzyme pair. Nat. Struct. Mol. Biol. 2004, 11:945-949.
34. Fraser J.S., Clarkson M.W., Degnan S.C., Erion R., Kern D., Alber T. Hidden alternative structures of proline isomerase essential for catalysis. Nature 2009, 462:669-673.
35. Pervushin K., Riek R., Wider G., Wuthrich K. Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc. Natl Acad. Sci. USA 1997, 94:12366-12371.
36. Loria J.P., Rance M., Palmer A.G. A TROSY CPMG sequence for characterizing chemical exchange in large proteins. J. Biomol. NMR 1999, 15:151-155.
37. Tollinger M., Skrynnikov N.R., Mulder F.A., Forman-Kay J.D., Kay L.E. Slow dynamics in folded and unfolded states of an SH3 domain. J. Am. Chem. Soc. 2001, 123:11341-11352.
38. Ottiger M., Zerbe O., Guntert P., Wuthrich K. The NMR solution conformation of unligated human cyclophilin A. J. Mol. Biol. 1997, 272:64-81.
39. Gitti R.K., Lee B.M., Walker J., Summers M.F., Yoo S., Sundquist W.I. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science 1996, 273:231-235.
40. Schlegel J., Armstrong G.S., Redzic J.S., Zhang F., Eisenmesser E.Z. Characterizing and controlling the inherent dynamics of cyclophilin-A. Protein Sci. 2009, 18:811-824.
41. Yoo S., Myszka D.G., Yeh C., McMurray M., Hill C.P., Sundquist W.I. Molecular recognition in the HIV-1 capsid/cyclophilin A complex. J. Mol. Biol. 1997, 269:780-795.
42. Ishima R., Torchia D.A. Error estimation and global fitting in transverse-relaxation dispersion experiments to determine chemical-exchange parameters. J. Biomol. NMR 2005, 32:41-54.
43. Millet O., Loria J.P., Kroenke C.D., Pons M., Palmer A.G. The static magnetic field dependence of chemical exchange linebroadening defines the NMR chemical shift time scale. J. Am. Chem. Soc. 2000, 122:2867-2877.
44. Braaten D., Ansari H., Luban J. The hydrophobic pocket of cyclophilin is the binding site for the human immunodeficiency virus type 1 Gag polyprotein. J. Virol. 1997, 71:2107-2113.
45. Dorfman T., Weimann A., Borsetti A., Walsh C.T., Gottlinger H.G. Active-site residues of cyclophilin A are crucial for its incorporation into human immunodeficiency virus type 1 virions. J. Virol. 1997, 71:7110-7113.
46. Bose S., Mathur M., Bates P., Joshi N., Banerjee A.K. Requirement for cyclophilin A for the replication of vesicular stomatitis virus New Jersey serotype. J. Gen. Virol. 2003, 84:1687-1699.
47. Helekar S.A., Patrick J. Peptidyl prolyl cis-trans isomerase activity of cyclophilin A in functional homo-oligomeric receptor expression. Proc. Natl Acad. Sci. USA 1997, 94:5432-5437.
48. Hong F., Lee J., Song J.W., Lee S.J., Ahn H., Cho J.J., et al. Cyclosporin A blocks muscle differentiation by inducing oxidative stress and inhibiting the peptidyl-prolyl-cis-trans isomerase activity of cyclophilin A: cyclophilin A protects myoblasts from cyclosporin A-induced cytotoxicity. FASEB J. 2002, 16:1633-1635.
49. Lee J.P., Palfrey H.C., Bindokas V.P., Ghadge G.D., Ma L., Miller R.J., Roos R.P. The role of immunophilins in mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 1999, 96:3251-3256.
50. Pan H., Luo C., Li R., Qiao A., Zhang L., Mines M., et al. Cyclophilin A is required for CXCR4-mediated nuclear export of heterogeneous nuclear ribonucleoprotein A2, activation and nuclear translocation of ERK1/2, and chemotactic cell migration. J. Biol. Chem. 2008, 283:623-637.
51. Yang H., Chen J., Yang J., Qiao S., Zhao S., Yu L. Cyclophilin A is upregulated in small cell lung cancer and activates ERK1/2 signal. Biochem. Biophys. Res. Commun. 2007, 361:763-767.
52. Saphire A.C., Bobardt M.D., Gallay P.A. trans-Complementation rescue of cyclophilin A-deficient viruses reveals that the requirement for cyclophilin A in human immunodeficiency virus type 1 replication is independent of its isomerase activity. J. Virol. 2002, 76:2255-2262.
53. Fischer G., Bang H., Mech C. Determination of enzymatic catalysis for the cis-trans-isomerization of peptide binding in proline-containing peptides. Biomed. Biochim. Acta 1984, 43:1101-1111.
54. 15N longitudinal decay and chemical exchange rates of systems in slow equilibrium. J. Biomol. NMR 1994, 4:727-734.
55. Bosco D.A., Kern D. Catalysis and binding of cyclophilin A with different HIV-1 capsid constructs. Biochemistry 2004, 43:6110-6119.
56. Zhou W., Yang Q., Low C.B., Karthik B.C., Wang Y., Ryo A., et al. Pin1 catalyzes conformational changes of Thr-187 in p27Kip1 and mediates its stability through a polyubiquitination process. J. Biol. Chem. 2009, 284:23980-23988.
57. Baine P. Comparison of rate constants determined by two-dimensional NMR spectroscopy with rate constants determined by other NMR techniques. Magn. Reson. Chem. 1986, 24:304-307.
58. Chen Z.J., Vetter M., Chang G.D., Liu S., Che D., Ding Y., et al. Cyclophilin A functions as an endogenous inhibitor for membrane-bound guanylate cyclase-A. Hypertension 2004, 44:963-968.
59. Franke E.K., Yuan H.E., Luban J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 1994, 372:359-362.
60. Thali M., Bukovsky A., Kondo E., Rosenwirth B., Walsh C.T., Sodroski J., Gottlinger H.G. Functional association of cyclophilin A with HIV-1 virions. Nature 1994, 372:363-365.
61. Sayah D.M., Sokolskaja E., Berthoux L., Luban J. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 2004, 430:569-573.
62. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427:848-853.
63. Luban J. Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection. J. Virol. 2007, 81:1054-1061.
64. Mulder F.A., Skrynnikov N.R., Hon B., Dahlquist F.W., Kay L.E. Measurement of slow (micros-ms) time scale dynamics in protein side chains by (15)N relaxation dispersion NMR spectroscopy: application to Asn and Gln residues in a cavity mutant of T4 lysozyme. J. Am. Chem. Soc. 2001, 123:967-975.
65. Carver J.P., Richards R.E. A general two-site solution for the chemical exchange produced dependence of T2 upon the Carr-Purcell pulse separation. J. Magn. Reson. 1972, 6:89-105.
66. Binsch G. A unified theory of exchange effects on nuclear magnetic resonance line shapes. J. Am. Chem. Soc. 1969, 91:1304-1309.